|
American Society of Clinical Oncology. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: Guideline. Published online ahead of print November 1, 2021, DOI: 10.1200/JCO21.01440 |
|
|
European Society of Clinical Oncology. Management of toxicities from immunotherapy ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up J. Haanen, F. Carbonnel, C. Robert, K. Kerr, S. Peters, J. Larkin and K. Jordan, on behalf of the ESMO Guidelines Committee. 2018 |
|
|
European Society of Clinical Oncology. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: Guidelines. Published in 2017 – Ann Oncol (2017) 28 (suppl 4): iv119–iv142. Authors: J. Haanen, F. Carbonnel, C. Robert, K. Kerr, S. Peters, J. Larkin and K. Jordan |
|
|
Jornada «IV Simposio Internacional sobre Inmunoterapia del Cáncer» organizado por el IIS Aragón: Zaragoza, 8 de noviembre de 2022 |
|
|
Sociedad Española de Oncología Médica. Guía clínica SEOM de manejo de toxicidad por inmunoterapia 2019 – en colaboración con GETICA. 2019 |
